Evaluate the Treatment With Sintilimab Injection Plus Endostar in Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma Non-resectable Intervention: Sponsor: Huazhong University of Science and Technology Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials